129 related articles for article (PubMed ID: 18444984)
1. Antiviral therapy of hepatitis C in chronic kidney diseases: meta-analysis of controlled clinical trials.
Fabrizi F; Ganeshan SV; Lunghi G; Messa P; Martin P
J Viral Hepat; 2008 Aug; 15(8):600-6. PubMed ID: 18444984
[TBL] [Abstract][Full Text] [Related]
2. Pegylated interferon monotherapy of chronic hepatitis C in dialysis patients: Meta-analysis of clinical trials.
Fabrizi F; Dixit V; Messa P; Martin P
J Med Virol; 2010 May; 82(5):768-75. PubMed ID: 20336712
[TBL] [Abstract][Full Text] [Related]
3. Interferon monotherapy of chronic hepatitis C in dialysis patients: meta-analysis of clinical trials.
Fabrizi F; Dixit V; Messa P; Martin P
J Viral Hepat; 2008 Feb; 15(2):79-88. PubMed ID: 18184190
[TBL] [Abstract][Full Text] [Related]
4. Interferon therapy of acute hepatitis C in dialysis patients: meta-analysis.
Fabrizi F; Dixit V; Messa P; Martin P
J Viral Hepat; 2012 Nov; 19(11):784-91. PubMed ID: 23043385
[TBL] [Abstract][Full Text] [Related]
5. Treatment of hepatitis C after kidney transplant: a pooled analysis of observational studies.
Fabrizi F; Penatti A; Messa P; Martin P
J Med Virol; 2014 Jun; 86(6):933-40. PubMed ID: 24610278
[TBL] [Abstract][Full Text] [Related]
6. Combined antiviral therapy of hepatitis C virus in dialysis patients: meta-analysis of clinical trials.
Fabrizi F; Dixit V; Martin P; Messa P
J Viral Hepat; 2011 Jul; 18(7):e263-9. PubMed ID: 21108701
[TBL] [Abstract][Full Text] [Related]
7. Pegylated Interferon Mono-Therapy of Chronic Hepatitis C in the Dialysis Population: Systematic Review and Meta-Analysis.
Fabrizi F; Dixit V; Messa P; Martin P
Ther Apher Dial; 2015 Dec; 19(6):611-21. PubMed ID: 26197927
[TBL] [Abstract][Full Text] [Related]
8. Meta-analysis: interferon for the treatment of chronic hepatitis C in dialysis patients.
Fabrizi F; Dulai G; Dixit V; Bunnapradist S; Martin P
Aliment Pharmacol Ther; 2003 Dec; 18(11-12):1071-81. PubMed ID: 14653826
[TBL] [Abstract][Full Text] [Related]
9. Interferon-based anti-viral therapy for hepatitis C virus infection after renal transplantation: an updated meta-analysis.
Wei F; Liu J; Liu F; Hu H; Ren H; Hu P
PLoS One; 2014; 9(4):e90611. PubMed ID: 24699257
[TBL] [Abstract][Full Text] [Related]
10. Meta-analysis: anti-viral therapy of hepatitis C virus-related liver disease in renal transplant patients.
Fabrizi F; Lunghi G; Dixit V; Martin P
Aliment Pharmacol Ther; 2006 Nov; 24(10):1413-22. PubMed ID: 17081162
[TBL] [Abstract][Full Text] [Related]
11. Effect of interferon-alpha-based antiviral therapy on hepatitis C virus-associated glomerulonephritis: a meta-analysis.
Feng B; Eknoyan G; Guo ZS; Jadoul M; Rao HY; Zhang W; Wei L
Nephrol Dial Transplant; 2012 Feb; 27(2):640-6. PubMed ID: 21558431
[TBL] [Abstract][Full Text] [Related]
12. Efficacy and safety of direct-acting antivirals-based antiviral therapies for hepatitis C virus patients with stage 4-5 chronic kidney disease: a meta-analysis.
Li T; Qu Y; Guo Y; Wang Y; Wang L
Liver Int; 2017 Jul; 37(7):974-981. PubMed ID: 27943605
[TBL] [Abstract][Full Text] [Related]
13. Interferon therapy for HCV-associated glomerulonephritis: meta-analysis of controlled trials.
Fabrizi F; Bruchfeld A; Mangano S; Dixit V; Messa P; Martin P
Int J Artif Organs; 2007 Mar; 30(3):212-9. PubMed ID: 17417760
[TBL] [Abstract][Full Text] [Related]
14. Pegylated interferon (alone or with ribavirin) for chronic hepatitis C in haemodialysis population.
Espinosa M; Hernàndez J; Arenas MD; Carnicer F; Caramelo C; Fabrizi F
Kidney Blood Press Res; 2015; 40(3):258-65. PubMed ID: 25997572
[TBL] [Abstract][Full Text] [Related]
15. Interferon treatment in hemodialysis patients with chronic hepatitis C virus infection: a systematic review of the literature and meta-analysis of treatment efficacy and harms.
Gordon CE; Uhlig K; Lau J; Schmid CH; Levey AS; Wong JB
Am J Kidney Dis; 2008 Feb; 51(2):263-77. PubMed ID: 18215704
[TBL] [Abstract][Full Text] [Related]
16. [Experiences in antiviral treatment of chronic viral hepatitis B and C in Hungary (1998-2004)].
Pár A; Tornai I; Szalay F
Orv Hetil; 2007 May; 148(18):819-26. PubMed ID: 17468063
[TBL] [Abstract][Full Text] [Related]
17. Meta-analysis of interferon randomized trials in the treatment of viral hepatitis C: effects of dose and duration.
Poynard T; Leroy V; Cohard M; Thevenot T; Mathurin P; Opolon P; Zarski JP
Hepatology; 1996 Oct; 24(4):778-89. PubMed ID: 8855176
[TBL] [Abstract][Full Text] [Related]
18. Interferon and lamivudine combination therapy versus lamivudine monotherapy for hepatitis B e antigen-negative hepatitis B treatment: a meta-analysis of randomized controlled trials.
Shi Y; Wu YH; Shu ZY; Zhang WJ; Yang J; Chen Z
Hepatobiliary Pancreat Dis Int; 2010 Oct; 9(5):462-72. PubMed ID: 20943454
[TBL] [Abstract][Full Text] [Related]
19. Hepatitis C treatment in patients with kidney disease.
Fabrizi F; Aghemo A; Messa P
Kidney Int; 2013 Nov; 84(5):874-9. PubMed ID: 23823603
[TBL] [Abstract][Full Text] [Related]
20. Interferon monotherapy for dialysis patients with chronic hepatitis C: an analysis of the literature on efficacy and safety.
Russo MW; Goldsweig CD; Jacobson IM; Brown RS
Am J Gastroenterol; 2003 Jul; 98(7):1610-5. PubMed ID: 12873587
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
